Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
about
Breast cancer risk factorsThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskA genome wide study of genetic adaptation to high altitude in feral Andean Horses of the páramoThe divergence, actions, roles, and relatives of sodium-coupled bicarbonate transportersGenetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineOngoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers"Stop Ne(c)king around": How interactomics contributes to functionally characterize Nek family kinasesTwo decades after BRCA: setting paradigms in personalized cancer care and preventionMap making in the 21st century: charting breast cancer susceptibility pathways in rodent models.Clinical management of hereditary breast cancer syndromes.Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.A review of cancer risk prediction models with genetic variants.The SLC4 family of bicarbonate (HCO₃⁻) transporters.Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?Hereditary breast cancer: clinical, pathological and molecular characteristics.Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese.The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.Common low-penetrance risk variants associated with breast cancer in Polish women.The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patientsQuantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk.TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.Personalized medicine: new genomics, old lessonsAn epidemiological perspective of personalized medicine: the Estonian experience.Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association ConsortiumGenetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersBreast cancer risks and risk prediction models.Common variants modify the age of onset for basal cell carcinomas in Gorlin syndrome.Genotype in BRCA-associated breast cancersTen modifiers of BRCA1 penetrance validated in a Norwegian seriesRisk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.Common breast cancer susceptibility loci are associated with triple-negative breast cancer.Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients.Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers.Effect of simultaneously replacing putative TM6 and TM12 of human NBCe1-A with those from NBCn1 on surface abundance in Xenopus oocytes
P2860
Q26777289-8B032B85-D405-4B96-B054-8ECA68809186Q27003050-478C8F2C-E4E9-4596-A73B-BA24D6AA8E07Q27008356-CEB9773A-9D04-4A47-A621-8915D88626DFQ28660894-9F96E2DF-27B7-4AB0-83B5-F3BAB7D1B095Q30440948-4015AC7A-5582-4BC3-977D-8546DD227899Q30513982-94BBADB8-2A08-42BF-9AD9-ACBB4F719D11Q31001228-8FFEC23B-88AB-402C-AB60-18B86110E3F7Q31139519-CC79A843-EE0A-4C0F-925A-0D2F5D950517Q33614244-71CFFB80-A815-4B52-9232-B5197E2A8699Q33728829-F4812DF1-B88C-40B6-9AD8-A521A0513BD4Q33820594-107CEFD7-BC75-489A-A6D9-D6CD94403760Q33908246-9D3569E6-ADBB-4C37-B083-1FDCDDD340C5Q34167563-D68E3FB3-6471-419F-AB9F-936500E1B985Q34213403-96A8C345-3BF1-414F-A8B1-778DE93A3518Q34265269-3C38ABCB-9668-45AF-A7B5-1BE1B930D69AQ34333694-5030098F-A75B-4E53-A78B-3891229D83E4Q34339960-478483F0-0DD1-4EAF-B4A9-A68E186425C1Q34425230-83E4CA36-AC91-4C9F-8620-B6D1B7BBF712Q34447165-DF57F5C6-D821-434C-8117-397E0BB8D7C6Q34481713-EE947668-F40D-4C29-AC98-422FC94468AFQ34493797-BB4D87CD-572D-495E-9BEA-D36680B03059Q34523801-01C4D41A-472A-44BB-A8C0-079232F6359BQ34973472-68EE32D0-A144-4272-A4C7-BB762933096EQ35074030-BA2916F1-9BE3-4891-8A31-AD63A8771356Q35082635-D611B6A9-1685-4A5F-A5F7-1D89F2E54001Q35086233-9C70FC90-8CF8-4F40-BB86-302696DB50D7Q35119701-CD36EFD9-C757-46EF-BF95-4DF4E1307BD3Q35263848-FBF00279-4FC0-4599-B80E-C1B7C1FF69B8Q35382206-AA6FC076-0A8F-4571-8377-CAEEFBBFCB06Q35399596-7760A792-6CF3-4B0A-B99C-32514524064CQ35477995-3B2F9A19-B987-4700-94E6-9A2CFEF32895Q35624773-D5993B4E-94C6-406D-9BF9-3B2E957441D2Q35686538-6C339F35-96B0-4DC3-8F69-8F948C221E8DQ35815958-4D02E598-CB85-42CD-8A54-565FD5070BF9Q35870067-9F731A90-0C03-4DAB-B104-A33263002FC8Q35889575-8A64539F-36B7-4722-8F0A-E83B5F53EFE4Q35891162-8A5095A2-5599-44F9-942D-A2CECDDACD76Q36046753-9A9520B6-27C9-415D-B1A9-74E7009AE8C5Q36245609-C8BB126B-5050-4F0A-80B7-DDD758A0EB0CQ36257173-36EE7966-BA20-40EB-9CA2-E9D0D59949FC
P2860
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Common breast cancer susceptib ...... lications for risk prediction.
@ast
Common breast cancer susceptib ...... lications for risk prediction.
@en
Common breast cancer susceptib ...... lications for risk prediction.
@nl
type
label
Common breast cancer susceptib ...... lications for risk prediction.
@ast
Common breast cancer susceptib ...... lications for risk prediction.
@en
Common breast cancer susceptib ...... lications for risk prediction.
@nl
prefLabel
Common breast cancer susceptib ...... lications for risk prediction.
@ast
Common breast cancer susceptib ...... lications for risk prediction.
@en
Common breast cancer susceptib ...... lications for risk prediction.
@nl
P2093
P2860
P50
P1433
P1476
Common breast cancer susceptib ...... lications for risk prediction.
@en
P2093
Agnès Hardouin
Alexander Miron
Ana Dutra-Clarke
Andrew K Godwin
Ania Jakubowska
Anna Allavena
Anne Catharina Dressler
Antoine de Pauw
Beatrice Melin
P2860
P304
P356
10.1158/0008-5472.CAN-10-1907
P407
P50
P577
2010-11-30T00:00:00Z